Med Business World

Your source for healthcare business

Oskar Håland

Coloplast launches Peristeen® Light for people with bowel disorders

The new transanal irrigation device is designed to help people facing defecation issues or stool leakage. It is estimated that 10-15% of the world’s population are affected by chronic constipation1 and that 6% struggle with faecal incontinence2, both of which can…

Johnson & Johnson’s nipocalimab granted U.S. FDA Breakthrough Therapy Designation for the treatment of individuals at high risk for severe hemolytic disease of the fetus and newborn (HDFN)

Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for nipocalimab for the treatment of alloimmunizeda pregnant individuals at high risk of severe hemolytic disease of the fetus and newborn (HDFN)….

Securing the Future: A Comprehensive Analysis of Emerging Cyber Threats Targeting Healthcare Systems

The author of this article is Mr Raj Sivaraju, President, APAC, Arete In a country’s socioeconomic landscape, the healthcare sector stands as a key pillar, bolstering the essence of a thriving economy. India, a burgeoning force in the global economy, grapples…

Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients suffering from cancer, announces it plans to expand the…

YASHODA HOSPITALS, Hyderabad SUCCESSFULLY TREATS ELDERLY MAN WITH CA. BUCCAL MUCOSA INFILTRATING INTO MANDIBLE

Yashoda Hospitals (Malakpet) Hyderabad, a leading healthcare institution, has successfully treated  an elderly man aged 57 from Warrangal suffering from CA. Buccal Mucosa, commonly known as oral cancer. The patient was first admitted under Dr. Hari Krishna Reddy. K, Consultant…

Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin-Angiotensin System, today announced that the first patient has been dosed in the Company’s phase 2 clinical trial of TXA127, the Company’s lead peptide product under…

Newton Dentist Utilizes Oral Appliance Therapy to Treat Sleeping Disorders

Newton Dentistry provides a range of treatment options for snoring patients and sleep apnea patients. Dr. Yoon Ji Jang, who has experience in dental sleep medicine as well as sedation, provides sleep apnea treatment as an alternative to continuous positive airway…

Signia Marks a New Era with the Inauguration of its 350th BestSound Center in Partnership with HearSens Hearing Clinic in Hyderabad

Signia, a distinguished brand within the WS Audiology group and a leader in hearing aid innovation, celebrates a significant milestone with the launch of its 350th BestSound Center in Hyderabad. This milestone underscores Signia’s pivotal role in revolutionizing hearing care…

Johnson & Johnson Submits Supplemental Biologics License Application and New Drug Application to U.S. FDA Seeking Approval of RYBREVANT® (amivantamab-vmjw) Plus Lazertinib for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)

Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) together with a New Drug Application (NDA) seeking the approval of RYBREVANT® (amivantamab-vmjw) in combination with lazertinib for the…

Novel Brain Stimulation Technique Shows Promise in Patients with Hard-to-Treat Depression

By making slight modifications to an already approved brain stimulation technique called transcranial magnetic stimulation (TMS), researchers have reported profound improvement in patients with hard-to-treat depression. Overall, 66% of patients with major depressive disorder who took part in the study responded…